2017 Executive Sponsors
2017 Associate Sponsors
2017 Media Partners
2017 Executive Sponsors
Bioclinica provides Imaging Core Lab services for Independent Medical Image Review, ECG and Blood Pressure assessment and Biochemical Marker Analysis for clinical trials. Bioclinica’s scientific and regulatory expertise brings clarity to the clinical trial process and reveals key trial data insights to advance oncology drug research. Spanning 30+ years, 1100+ oncology trials and 56 FDA-approved oncology drugs, our medical experience delivers high quality data in support of safer cancer drugs. Learn more at www.bioclinica.com.
Imaging Endpoints (IE) is a mission driven research and imaging CRO with offices in Scottsdale, Arizona and Waltham, Massachusetts. We specialize in providing the industry’s leading imaging expertise and most advanced technologies coupled with exquisite services. Our experience extends from translational to phase 3 trials and every step in-between. Our organization is unique in that it is owned by a team of over 40 in-house radiologists and nuclear medicine physicians that specialize in advanced imaging technologies. Our comprehensive services span all aspects of trial planning and conduct, including protocol development, site qualification and standardization, real-time image receipt/QC and reads, data management, regulatory compliance and preparation for meetings/submissions to regulatory authorities. Our Rapid Detection and Assessment of Response program (RaDAR) is designed to accelerate product development by integrating the most advanced imaging technologies into clinical trials. At Imaging Endpoints, our capabilities go above and beyond the typical imaging core lab offering. Learn more at www.imagingendpoints.com
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation, it can be used to predict response of an indication to a specific drug (or drug combination), or to better understand MOA of a given compound. Founded in 2010, Mitra is headquartered in Boston and maintains a significant research and laboratory presence in Bangalore, India. Learn more about us at www.mitrabiotech.com
nanoString Technologies provides life science tools for translational research and molecular diagnostics. nCounter® digital molecular barcoding enables simultaneous measurement of hundreds of genes, miRNAs, proteins, or copy number variations. Precise and highly sensitive, this technology facilitates numerous applications including NanoString’s first diagnostic product, the Prosigna® Prognostic Breast Cancer Gene Signature Assay. Learn more at www.nanostring.com.
NeoGenomics is a premier cancer diagnostics and pharma services company. We serve the needs of oncologists, pathologists, pharmaceutical companies, academic centers, and other healthcare professionals with innovative diagnostic, prognostic and predictive testing. We provide anatomic pathology, flow cytometry, FISH, cytogenetics, molecular, and genomic technologies. Our experience with companion and complementary diagnostics is unparalleled and we are the lab of choice for the pharma industry for clinical trial lab services. Visit www.neogenomics.com.
Supported by McKesson Specialty Health and The US Oncology Network, US Oncology Research draws from a network of experienced investigators and dedicated clinical staff who specialize in oncology clinical trials. US Oncology Research serves approximately 60 research sites, 150 locations, and manages 300 active trials at any given time. Physicians in the research network have enrolled more than 63,000 patients in 1,500 trials since inception in 1992 and played a role in more than 60 FDA-approved cancer therapies – nearly one-third of all approved cancer therapies – to date. For more information, visit www.usoncology.com.
2017 Associate Sponsors
Adaptive Biotechnologies is the pioneer and leader in combining high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories around the world to drive groundbreaking research in cancer and other immune-mediated diseases. Adaptive also translates immunosequencing discoveries into clinical diagnostics and therapeutic development to improve patient care. Learn more at www.adaptivebiotech.com
BeiGene is a global biotechnology company focused on the discovery and development of innovative drugs to treat cancer. Our drug discovery engine has generated four assets entering late-stage clinical development, as well as several drugs in preclinical development. Each program has potential meaningful differentiation, and our broad portfolio offers opportunities for combinations. BeiGene has access to huge numbers of patients in China that enable us to better identify therapies with the potential to be best-in-class treatments. Learn more about us at www.beigene.com
BioLegend develops and manufactures world-class, cutting-edge antibodies and reagents at an outstanding value. The broad product portfolio includes flow cytometry, cell biology, and functional reagents for research in immunology, neuroscience, cancer, and stem cells. Custom services include assay development, sample testing, and conjugation. BioLegend is certified for ISO 9001:2008 and ISO 13485:2003. Learn more at www.biolegend.com
At Cytel, we believe that expert statistical input increases the probability of trial success. Our consulting statisticians support a range of issues from complex trial designs, to development program strategy. All the leading pharmaceutical, biotech and medical devices companies use Cytel’s software for clinical trial design, analysis and implementation. For more information, visit www.cytel.com.
Defined Health is a leading biopharmaceutical asset development strategy consultancy with 25+ years of experience. Our consultants hold advanced degrees in science, medicine and business, and have industry experience in business development, commercial evaluation, finance, licensing, drug discovery and R&D. Our clients include top global pharma, large cap biotech, specialty pharma and hundreds of pre-commercial biotech and platform technology companies. Our work encompasses asset evaluation, early commercial strategy, indication prioritization and sequencing, life-cycle management and search and evaluation. Learn more at www.definedhealth.com.
Immodulon is a leading UK-based biopharmaceutical company pioneering immunotherapy treatments, in particular for cancer. Immodulon’s focus lies predominantly in melanoma and pancreatic cancer treatments. Its flagship product IMM-101 is an immune-modulator and a naturally derived medical treatment that helps the immune system recognise and control cancer.Visit us at www.immodulon.com
inVentiv Health is a global professional services organization designed to help the biopharmaceutical industry accelerate the delivery of much-needed therapies to market. Our combined Clinical Research Organization (CRO) and Contract Commercial Organization (CCO) offer a differentiated suite of services, processes and integrated solutions that improve client performance. With more than 15,000 employees and the ability to support clients in more than 90 countries, our global scale and deep therapeutic expertise enable inVentiv to help clients successfully navigate an increasingly complex environment. For more information, visit inVentivHealth.com
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms. The combination of MacroGenics’ technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. Read more about us at www.macrogenics.com
Miltenyi Biotec provides products that advance biomedical research and cellular therapy. Our innovative tools support research from basic research to translational research to clinical application. Our more than 25 years of expertise includes immunology, stem cell biology, neuroscience, and cancer. Miltenyi Biotec has more than 1,700 employees in 25 countries. Learn more about us at http://www.miltenyibiotec.com/en/
Neon Therapeutics is an immuno-oncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer. A neoantigen-based product engine allows Neon to develop multiple treatment modalities, including next-generation vaccines and T cell therapies targeting both personalized and shared neoantigens. Neon’s lead program is a personalized neoantigen vaccine that builds upon years of research and development at the Broad Institute and Dana-Farber Cancer Institute, and is already in clinical trials. For more information, please visit www.neontherapeutics.com.
PAREXEL ® Informatics is a global leader in helping pharmaceutical and biotech companies employ time- and budget-saving medical imaging in clinical trials. Our expertise spans a wide-range of therapeutic areas including Oncology, Musculoskeletal, Neurology, Cardiovascular, Women's Health, Gastroenterology, Ophthalmology, Respiratory and Pulmonology, Dermatology and Volumetric. For more information, visit www.PAREXEL.com.
Vector Vitale, Inc is an interdisciplinary research-based company focused on development and commercialization of a new type of medicine: isotope-selective diagnostics, therapy, prevention of diseases and aging. For more information, please visit us at: http://vectorvitale.com
As an innovator in reagents and tools, Abcam’s purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly validated biological binders and assays to address important targets in critical biological pathways. Learn more at www.abcam.com
Axio Research offers a comprehensive range of statistical genetics and genomics services to clients undertaking drug discovery and companion diagnostics development. Merging deep experience in statistical genetics, bioinformatics, and biostatistics with clinical understanding, Axio applies leading-edge statistical and computational methods to support and expedite genomic discovery. Reach us at: info@AxioResearch.com. Learn more about us at www.axioresearch.com.
Caprion is a specialty CRO providing laboratory services to pharmaceutical/biotechnology companies with GCP/GLP/GCLP capabilities. Caprion’s ImmuneCarta® Division, offers multi-parametric flow cytometry, cytokine testing, and ELISpot for analyses of innate and adaptive immune responses. Caprion’s ProteoCarta™ Division leverages its expertise in mass spectrometry for protein analysis in support of biomarkers development. Learn more about us at www.caprion.com
Intrinsic Imaging is an FDA audited, ISO 9001, ISO 13485 and ISO 22301 certified and GAMP® 5 compliant medical imaging core lab. At Intrinsic, we have the team, the technology and the therapeutic expertise to manage your entire medical imaging trial providing comprehensive services in support of Phase I-IV Clinical Trials. For more information, please visit www.intrinsicimaging.com
KIYATEC prioritizes accurate ex vivo prediction of patients’ drug response, focused primarily on data correlation to human clinical outcomes. Our drug response profiling services utilize phenotypic 3D cell-based models for predicting patient response. KIYATEC’s 3D perfusion tissue microenvironments are particularly useful for investigating the efficacy of both immuno-oncology therapies and chemotherapeutics. For more information, please visit us at www.kiyatec.com
Personalis, Inc is a leading precision medicine company focused on advanced NGS-based clinical diagnostic, clinical trial and research services for cancer and inherited genetic disease. Personalis also provides DNA sequencing and data analysis of human genomes. Our ACE Exome and Transcriptome technology is designed to obtain the most comprehensive and accurate tumor molecular profile for immuno-oncology applications. The company’s clinical laboratory is GCP compliant, CLIA licensed and CAP accredited. Visit www.personalis.com.
QuickSTAT is solely dedicated to providing supply chain solutions to the biopharmaceutical and life sciences industries, overseeing the transport investigational drugs, clinical research specimens, and managing the complex logistics requirements of immunotherapy trials and commercialization initiatives around the world. QuickSTAT provides consultation on regulatory compliance and specialized packaging solutions across all geographies and unique temperature requirements and successfully supported the R&D and clinical trial supply chain of the first ever approved FDA cancer vaccine. Learn more about us at http://quickstat.quick.aero
World Courier is a global specialty logistics company that designs world-class logistics and supply chain programs in complete alignment with our customers’ business goals. At World Courier we help our clients optimize pharmaceutical transport costs by ensuring that their investigational drugs, clinical trial supplies, biological samples and commercial products consistently arrive on time and in within desired temperature range. With 2,000+ associates in more than 140 offices across the globe, we offer solutions that instill confidence in the on-time, on-temperature delivery of critical products. To learn more, visit www.worldcourier.com.